NCT00463762View on ClinicalTrials.gov

Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

May 31, 2007

Conditions
Abscess, Intra-AbdominalCholecystitisWound InfectionsPeritonitisAppendicitis
Interventions
DRUG

CP-75385-02 Cefoperazone/sulbactam

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY